QGEN Qiagen NV
- Stocks
- Healthcare
- NYSE: QGEN
Price (delayed)
$48.97
Market cap
$10.66B
P/E Ratio
28.81
Dividend/share
$1.51
EPS
$1.7
Enterprise value
$11.37B
qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from
Highlights
The price to earnings (P/E) is 67% lower than the last 4 quarters average of 88.2 and 38% lower than the 5-year quarterly average of 46.1
The gross profit has grown by 37% YoY and by 30% from the previous quarter
Qiagen's quick ratio has shrunk by 53% QoQ
The debt has grown by 3% year-on-year and by 2.5% since the previous quarter
Key stats
What are the main financial stats of QGEN
Market
Valuations
Earnings
Shares outstanding
217.69M
Market cap
$10.66B
Enterprise value
$11.37B
Price to earnings (P/E)
28.81
Price to book (P/B)
3.04
Price to sales (P/S)
5.24
EV/EBIT
21.61
EV/EBITDA
15.9
EV/Sales
5.57
Revenue
$2.04B
Gross profit
$1.28B
Operating income
$468.45M
Net income
$373.39M
EBIT
$526.2M
EBITDA
$715.14M
Free cash flow
$498.54M
Per share
Balance sheet
Liquidity
EPS
$1.7
EPS diluted
$1.7
Free cash flow per share
$2.28
Book value per share
$16.1
Revenue per share
$9.35
TBVPS
$13.56
Total assets
$5.82B
Total liabilities
$2.32B
Debt
$1.44B
Equity
$3.51B
Working capital
$690.68M
Debt to equity
0.41
Current ratio
1.61
Quick ratio
1.19
Net debt/EBITDA
0.99
Margins
Efficiency
Dividend
EBITDA margin
35.1%
Gross margin
63%
Net margin
18.3%
Operating margin
23%
Return on assets
6.4%
Return on equity
10.7%
Return on invested capital
18.3%
Return on capital employed
11.2%
Return on sales
25.8%
Dividend yield
3.08%
DPS
$1.51
Payout ratio
88.8%
QGEN stock price
How has the Qiagen stock price performed over time
Intraday
2%
1 week
-1.96%
1 month
1.75%
1 year
8.22%
YTD
9.97%
QTD
1.89%
Financial performance
How have Qiagen's revenue and profit performed over time
Revenue
$2.04B
Gross profit
$1.28B
Operating income
$468.45M
Net income
$373.39M
Gross margin
63%
Net margin
18.3%
The gross profit has grown by 37% YoY and by 30% from the previous quarter
Qiagen's gross margin has increased by 30% YoY and by 28% QoQ
The company's revenue rose by 5% YoY
Price vs fundamentals
How does QGEN's price correlate with its fundamentals
Growth
What is Qiagen's growth rate over time
Valuation
What is Qiagen stock price valuation
P/E
28.81
P/B
3.04
P/S
5.24
EV/EBIT
21.61
EV/EBITDA
15.9
EV/Sales
5.57
The price to earnings (P/E) is 67% lower than the last 4 quarters average of 88.2 and 38% lower than the 5-year quarterly average of 46.1
The stock's price to book (P/B) is 9% more than its last 4 quarters average of 2.8 but 8% less than its 5-year quarterly average of 3.3
QGEN's equity is up by 2.9% YoY and by 2.9% QoQ
QGEN's price to sales (P/S) is 7% higher than its last 4 quarters average of 4.9
The company's revenue rose by 5% YoY
Efficiency
How efficient is Qiagen business performance
The company's return on invested capital has surged by 195% QoQ
Qiagen's ROS has soared by 190% from the previous quarter
Dividends
What is QGEN's dividend history
DPS
$1.51
Dividend yield
3.08%
Payout ratio
88.8%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Qiagen financials performed over time
Qiagen's total assets is 151% higher than its total liabilities
Qiagen's quick ratio has shrunk by 53% QoQ
The current ratio has plunged by 52% from the previous quarter and by 9% YoY
The debt is 59% smaller than the equity
The debt has grown by 3% year-on-year and by 2.5% since the previous quarter
QGEN's equity is up by 2.9% YoY and by 2.9% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.